Exelixis Inc Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
Exelixis Inc (EXEL) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-27.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2017-02-27
- Exelixis Inc gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Exelixis Inc gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2015 was $1.00M, a 66.67% increase from fiscal 2014.
- Exelixis Inc gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2014 was $600.00K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-27 |
| 2015-12-31 | $1.00M 10-K · filed 2017-02-27 |
| 2014-12-31 | $600.00K 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |